2000
DOI: 10.1016/s0732-8893(99)00152-2
|View full text |Cite
|
Sign up to set email alerts
|

A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
61
0
2

Year Published

2003
2003
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(71 citation statements)
references
References 14 publications
8
61
0
2
Order By: Relevance
“…The inoculum was allowed to dry, and both the disks and the Etest strips were placed on the same plates. The plates were incubated in air at 35°C, and the zone diameters surrounding the fluconazole and voriconazole disks were read at 24 h. Zone diameter endpoints were read at 80% growth inhibition by using the BIOMIC image analysis plate reader system (version 5.9; Giles Scientific, Santa Barbara, Calif.) (5).…”
Section: Organismsmentioning
confidence: 99%
See 1 more Smart Citation
“…The inoculum was allowed to dry, and both the disks and the Etest strips were placed on the same plates. The plates were incubated in air at 35°C, and the zone diameters surrounding the fluconazole and voriconazole disks were read at 24 h. Zone diameter endpoints were read at 80% growth inhibition by using the BIOMIC image analysis plate reader system (version 5.9; Giles Scientific, Santa Barbara, Calif.) (5).…”
Section: Organismsmentioning
confidence: 99%
“…QC determinations made on each day of testing were within the control limits for fluconazole and voriconazole described by Barry et al (2). QC for disk diffusion testing was performed by using C. albicans ATCC 90028 and C. parapsilosis ATCC 22019 (3,5).…”
Section: Organismsmentioning
confidence: 99%
“…It acts by blocking the synthesis of ergosterol, an essential component of the fungal cell membrane (15). Clinical efficacy of topical antifungal therapy depends on the drug ability to penetrate into the SC and the duration of treatment (16). Hence, ME formulations appeared to be a viable approach for future topical delivery of FLZ.…”
Section: Introductionmentioning
confidence: 99%
“…Recent studies (2,4,9,11,13,14,19; C. Durussel, A. M. Daoui-Hassani, and J. Bille, Abstr. 38th Intersci.…”
mentioning
confidence: 99%